Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-Dabigatran Surveillance.

Inoue H, Uchiyama S, Atarashi H, Okumura K, Koretsune Y, Yasaka M, Yamashita T, Taniguchi A, Fukaya T; J-Dabigatran Surveillance Investigators.

J Cardiol. 2019 Mar 11. pii: S0914-5087(19)30044-9. doi: 10.1016/j.jjcc.2019.02.008. [Epub ahead of print]

PMID:
30871851
2.

Rivaroxaban administration after acute ischemic stroke: The RELAXED study.

Yasaka M, Minematsu K, Toyoda K, Mori E, Hirano T, Hamasaki T, Yamagami H, Nagao T, Yoshimura S, Uchiyama S; RELAXED study group.

PLoS One. 2019 Feb 13;14(2):e0212354. doi: 10.1371/journal.pone.0212354. eCollection 2019.

3.

Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study.

Koretsune Y, Kusakawa K, Harada KH, Koizumi A, Uchiyama S, Atarashi H, Okumura K, Yasaka M, Yamashita T, Taniguchi A, Fukaya T, Inoue H; for J-dabigatran surveillance and JAPAF study investigators.

Cardiol Ther. 2019 Feb 11. doi: 10.1007/s40119-019-0129-2. [Epub ahead of print]

PMID:
30746608
4.

Safety of tooth extraction in patients receiving direct oral anticoagulant treatment versus warfarin: a prospective observation study.

Yoshikawa H, Yoshida M, Yasaka M, Yoshida H, Murasato Y, Fukunaga D, Shintani A, Okada Y.

Int J Oral Maxillofac Surg. 2019 Feb 8. pii: S0901-5027(19)30030-X. doi: 10.1016/j.ijom.2019.01.013. [Epub ahead of print]

PMID:
30745243
5.

Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-dabigatran surveillance.

Inoue H, Uchiyama S, Atarashi H, Okumura K, Koretsune Y, Yasaka M, Yamashita T, Taniguchi A, Fukaya T; J-Dabigation Surveillance Investigators.

J Cardiol. 2019 Feb 5. pii: S0914-5087(18)30366-6. doi: 10.1016/j.jjcc.2018.12.013. [Epub ahead of print]

PMID:
30737182
6.

Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis.

Koretsune Y, Yamashita T, Yasaka M, Ono Y, Hirakawa T, Ishida K, Kuroki D, Sumida T, Urushihara H.

J Cardiol. 2019 Mar;73(3):204-209. doi: 10.1016/j.jjcc.2018.09.004. Epub 2018 Nov 23.

7.

Time-of-flight MRA signal intensity predicts the cerebral hemodynamic status after superficial temporal artery to middle cerebral artery anastomosis.

Matsuo S, Nakamizo A, Fujioka Y, Amano T, Yasaka M, Okada Y, Nagata S.

J Clin Neurosci. 2019 Jan;59:124-129. doi: 10.1016/j.jocn.2018.10.116. Epub 2018 Nov 3.

PMID:
30396815
8.

Coagulation Factor Plasma Levels Following Administration of a 4-Factor Prothrombin Complex Concentrate for Rapid Vitamin K Antagonist Reversal in Japanese Patients.

Yasaka M, Brainsky A, Zhang P, Kushimoto S.

Curr Ther Res Clin Exp. 2018 Aug 25;89:21-26. doi: 10.1016/j.curtheres.2018.08.001. eCollection 2018.

9.

Long-Term Neurocognitive Outcomes in Patients with Adult Moyamoya Disease.

Nakamizo A, Amano T, Michiwaki Y, Kawano Y, Kuwashiro T, Yasaka M, Okada Y.

World Neurosurg. 2018 Nov;119:e441-e448. doi: 10.1016/j.wneu.2018.07.179. Epub 2018 Jul 30.

PMID:
30071332
10.

Patient-reported treatment satisfaction with rivaroxaban in Japanese non-valvular atrial fibrillation patients: an observational study.

Koretsune Y, Kumagai K, Uchiyama S, Yamashita T, Yasaka M, Watanabe-Fujinuma E, Banderas BF, Akiyama S, Okayama Y, Briere JB, Dickie G, Cano SJ.

Curr Med Res Opin. 2018 Dec;34(12):2157-2164. doi: 10.1080/03007995.2018.1507315. Epub 2018 Aug 14.

PMID:
30067119
11.

Safety, pharmacokinetics and pharmacodynamics of idarucizumab, a specific dabigatran reversal agent in healthy Japanese volunteers: a randomized study.

Yasaka M, Ikushima I, Harada A, Imazu S, Taniguchi A, Norris S, Gansser D, Stangier J, Schmohl M, Reilly PA.

Res Pract Thromb Haemost. 2017 Aug 5;1(2):202-215. doi: 10.1002/rth2.12029. eCollection 2017 Oct.

12.

Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry.

Inoue H, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, Koretsune Y, Shimizu W, Tsutsui H, Toyoda K, Hirayama A, Yasaka M, Yamaguchi T, Akishita M, Hasebe N, Kario K, Mizokami Y, Nagata K, Nakamura M, Terauchi Y, Yamamoto T, Teramukai S, Kimura T, Kaburagi J, Takita A.

J Cardiol. 2018 Oct;72(4):300-306. doi: 10.1016/j.jjcc.2018.02.018. Epub 2018 Apr 3.

PMID:
29625717
13.

A survey of reasons for continuing warfarin therapy in the era of direct oral anticoagulants in Japanese patients with atrial fibrillation: the SELECT study.

Ikeda T, Yasaka M, Kida M, Imura M.

Patient Prefer Adherence. 2018 Jan 17;12:135-143. doi: 10.2147/PPA.S152584. eCollection 2018.

14.

Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study.

Koretsune Y, Ikeda T, Kozuma K, Hirano T, Yasaka M, Kida M, Chachin M, Imura M.

Patient Prefer Adherence. 2017 Dec 15;11:1987-1996. doi: 10.2147/PPA.S152579. eCollection 2017.

15.

Recurrent Stroke and Bleeding Events after Acute Cardioembolic Stroke-Analysis Using Japanese Healthcare Database from Acute-Care Institutions.

Yasaka M, Koretsune Y, Yamashita T, Oda E, Matsubayashi D, Ota K, Kobayashi M, Matsushita Y, Kaburagi J, Ibusuki K, Takita A, Iwashita M, Yamaguchi T.

J Stroke Cerebrovasc Dis. 2018 Apr;27(4):1012-1024. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.002. Epub 2017 Dec 12.

PMID:
29246672
16.

Long-Term Effect of Pravastatin on Carotid Intima-Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke).

Koga M, Toyoda K, Minematsu K, Yasaka M, Nagai Y, Aoki S, Nezu T, Hosomi N, Kagimura T, Origasa H, Kamiyama K, Suzuki R, Ohtsuki T, Maruyama H, Kitagawa K, Uchiyama S, Matsumoto M; J-STARS Investigators.

Stroke. 2018 Jan;49(1):107-113. doi: 10.1161/STROKEAHA.117.018387. Epub 2017 Nov 30.

17.

Factors Associated with Intima-Media Complex Thickness of the Common Carotid Artery in Japanese Noncardioembolic Stroke Patients with Hyperlipidemia: The J-STARS Echo Study.

Wada S, Koga M, Toyoda K, Minematsu K, Yasaka M, Nagai Y, Aoki S, Nezu T, Hosomi N, Kagimura T, Origasa H, Kamiyama K, Suzuki R, Ohtsuki T, Maruyama H, Kitagawa K, Uchiyama S, Matsumoto M; Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study Collaborators.

J Atheroscler Thromb. 2018 Apr 1;25(4):359-373. doi: 10.5551/jat.41533. Epub 2017 Nov 8.

18.

Improvement and Aggravation of Spontaneous Unruptured Vertebral Artery Dissection.

Shibahara T, Yasaka M, Wakugawa Y, Maeda K, Uwatoko T, Kuwashiro T, Lip GYH, Okada Y.

Cerebrovasc Dis Extra. 2017;7(3):153-164. doi: 10.1159/000481442. Epub 2017 Oct 17.

19.

Association between the maximal distance of atrial septal protrusion and cryptogenic stroke.

Tokunaga K, Yasaka M, Kuwashiro T, Gotoh S, Nakamura A, Takaguchi G, Ago T, Kamouchi M, Kitazono T, Okada Y.

Int J Stroke. 2017 Dec;12(9):941-945. doi: 10.1177/1747493016685721. Epub 2016 Dec 20.

PMID:
28885101
20.

Impact of antithrombotic treatment on clinical outcomes after craniotomy for unruptured intracranial aneurysm.

Nakamizo A, Michiwaki Y, Kawano Y, Amano T, Matsuo S, Fujioka Y, Tsumoto T, Yasaka M, Okada Y.

Clin Neurol Neurosurg. 2017 Oct;161:93-97. doi: 10.1016/j.clineuro.2017.08.016. Epub 2017 Aug 30.

PMID:
28865323
21.

Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study.

Kushimoto S, Fukuoka T, Kimura A, Toyoda K, Brainsky A, Harman A, Chung T, Yasaka M.

Int J Hematol. 2017 Dec;106(6):777-786. doi: 10.1007/s12185-017-2311-4. Epub 2017 Aug 16.

PMID:
28815410
22.

Prothrombin Complex Concentrate for Vitamin K Antagonist-Associated Intracranial Hemorrhage - Global Evidence and the Japanese Perspective.

Yasaka M, Brainsky A, Toyoda K.

Circ J. 2017 Oct 25;81(11):1564-1573. doi: 10.1253/circj.CJ-17-0428. Epub 2017 Jul 19. Review.

23.

[Measurement of Prothrombin Fragment 1+2 for the Assessment of Anticoagulant Activity in Patients Treated with Warfarin or Non-vitamin K Antagonist Oral Anticoagulant].

Tomoda M, Yasaka M, Nakanishi Y, Takaguchi G, Nakamura A, Gotoh S, Kuwashiro T, Okada Y.

Brain Nerve. 2017 May;69(5):571-576. doi: 10.11477/mf.1416200784. Japanese.

PMID:
28479535
24.

[Non-Convulsive Status Epilepticus Caused by Hyponatremia in an Elderly Woman: A Case Report].

Kurauchi Y, Yasaka M, Tokunaga K, Saito M, Shimohama S, Okada Y.

Brain Nerve. 2017 Apr;69(4):489-492. doi: 10.11477/mf.1416200769. Japanese.

PMID:
28424403
25.

Usefulness of a healthcare database for epidemiological research in atrial fibrillation.

Koretsune Y, Yamashita T, Yasaka M, Oda E, Matsubayashi D, Ota K, Kobayashi M, Matsushita Y, Kaburagi J, Ibusuki K, Takita A, Iwashita M, Yamaguchi T.

J Cardiol. 2017 Aug;70(2):169-179. doi: 10.1016/j.jjcc.2016.10.015. Epub 2016 Dec 24.

26.

The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study: Rationale and Trial Protocol.

Toyoda K, Minematsu K, Yasaka M, Nagai Y, Hosomi N, Origasa H, Kitagawa K, Uchiyama S, Koga M, Matsumoto M; J-STARS Investigators.

J Stroke Cerebrovasc Dis. 2017 Mar;26(3):595-599. doi: 10.1016/j.jstrokecerebrovasdis.2016.11.113. Epub 2016 Dec 20.

PMID:
28010953
27.

[Anticoagulation for patients with non-valvular atrial fibrillation].

Mizoguchi T, Yasaka M.

Nihon Rinsho. 2016 Apr;74(4):627-33. Review. Japanese.

PMID:
27333751
28.

Identification of Covert Atrial Fibrillation in Cryptogenic Ischemic Stroke: Current Clinical Practice in Japan.

Toyoda K, Okumura K, Hashimoto Y, Ikeda T, Komatsu T, Hirano T, Fukuda H, Matsumoto K, Yasaka M.

J Stroke Cerebrovasc Dis. 2016 Aug;25(8):1829-37. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.012. Epub 2016 Jun 6. Review.

PMID:
27282299
29.

[Repeated Cerebellar Hemorrhage Related to Rivaroxaban and Apixaban: A Case Report].

Yokoi M, Toyama Y, Tsurusaki Y, Nakamura A, Mima Y, Kuwashiro T, Wakugawa Y, Yasaka M, Okada Y.

Brain Nerve. 2016 May;68(5):573-7. doi: 10.11477/mf.1416200440. Japanese.

PMID:
27156511
30.

Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.

Nakamura A, Kuroda J, Ago T, Hata J, Matsuo R, Arakawa S, Kuwashiro T, Yasaka M, Okada Y, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.

Cerebrovasc Dis. 2016;42(3-4):196-204. doi: 10.1159/000445723. Epub 2016 Apr 26.

PMID:
27111222
31.

Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance.

Inoue H, Uchiyama S, Atarashi H, Okumura K, Koretsune Y, Yasaka M, Yamashita T, Ohnishi M, Yagi N, Fukaya T; J-Dabigatran Surveillance Investigators.

J Arrhythm. 2016 Apr;32(2):145-50. doi: 10.1016/j.joa.2015.11.008. Epub 2016 Jan 16.

32.

Aggressive Angiomyxoma of the Vulva with No Recurrence on a 5-year Follow up: A Case Report.

Narayama C, Ikeda M, Yasaka M, Sagara YS, Kan-no Y, Hayashi I, Narita A, Asai S, Tajima T, Shida M, Hirasawa T, Mikami M.

Tokai J Exp Clin Med. 2016 Mar 20;41(1):42-5.

33.

Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.

Yasaka M, Minematsu K, Toyoda K, Yamagami H, Yoshimura S, Nagao T, Mori E, Hirano T, Hamasaki T, Yamaguchi T.

J Stroke Cerebrovasc Dis. 2016 Jun;25(6):1342-8. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.035. Epub 2016 Mar 14.

PMID:
26987488
34.

Innovative Edoxaban Overcomes Undesirable Characteristics of Warfarin in East Asian Patients.

Yasaka M.

Circ J. 2016;80(4):811-3. doi: 10.1253/circj.CJ-16-0189. Epub 2016 Mar 9. No abstract available.

35.

Impact of Metformin on the Severity and Outcomes of Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus.

Mima Y, Kuwashiro T, Yasaka M, Tsurusaki Y, Nakamura A, Wakugawa Y, Okada Y.

J Stroke Cerebrovasc Dis. 2016 Feb;25(2):436-46. doi: 10.1016/j.jstrokecerebrovasdis.2015.10.016. Epub 2015 Dec 22.

PMID:
26725260
36.

New Insights into Nonvitamin K Antagonist Oral Anticoagulants' Reversal of Intracerebral Hemorrhage.

Yasaka M.

Front Neurol Neurosci. 2015;37:93-106. doi: 10.1159/000437116. Epub 2015 Nov 12. Review.

PMID:
26588018
37.

Low-dose warfarin with prothrombin time-international normalized ratio between 1.6 and 2.6 for very old Japanese patients.

Yasaka M.

Circ J. 2015;79(11):2314-6. doi: 10.1253/circj.CJ-15-1004. Epub 2015 Oct 1. No abstract available.

38.

Lipid is absorbed in the stomach by epithelial neoplasms (adenomas and early cancers): a novel functional endoscopy technique.

Ohtsu K, Yao K, Matsunaga K, Nagahama T, Kanemitsu T, Matsushima Y, Yasaka M, Ono Y, Fujiwara S, Hisabe T, Takaki Y, Hirai F, Matsui T, Hanada T, Imamura K, Tanabe H, Iwashita A, Shimokawa T.

Endosc Int Open. 2015 Aug;3(4):E318-22. doi: 10.1055/s-0034-1392095. Epub 2015 Jun 12.

39.

[A case of a simple ulcer associated with ulcerative colitis that demonstrated a good clinical response to infliximab].

Kishi M, Sou S, Ishihara H, Terabe H, Yasaka M, Kuhara K, Takeda T, Shimokoube M, Morimitsu Y, Miyazono K.

Nihon Shokakibyo Gakkai Zasshi. 2015;112(9):1682-8. doi: 10.11405/nisshoshi.112.1682. Japanese.

PMID:
26346358
40.

Safety and Management of Antithrombotic Therapy with Intra-Arterial Catheter Procedures.

Mima Y, Yasaka M, Wakugawa Y, Okada Y.

Intern Med. 2015;54(17):2115-20. doi: 10.2169/internalmedicine.54.4071. Epub 2015 Sep 1.

41.

Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment.

Koretsune Y, Yamashita T, Kimura T, Fukuzawa M, Abe K, Yasaka M.

Circ J. 2015;79(7):1486-95. doi: 10.1253/circj.CJ-14-0942. Epub 2015 Apr 28.

42.

Comparing Patient and Physician Risk Tolerance for Bleeding Events Associated with Anticoagulants in Atrial Fibrillation-evidence from the United States and Japan.

Okumura K, Inoue H, Yasaka M, Gonzalez JM, Hauber AB, Levitan B, Yuan Z, Briere JB.

Value Health Reg Issues. 2015 May;6:65-72. doi: 10.1016/j.vhri.2015.03.016. Epub 2015 May 16.

PMID:
29698195
43.

[Impact of comprehensive stroke team combined with vascular neurologist, neurosurgeon and endovascular interventionist for acute stroke].

Okada Y, Sambongi Y, Tsurusaki Y, Tsumoto T, Nagata S, Yasaka M.

Rinsho Shinkeigaku. 2014;54(12):1214-6. doi: 10.5692/clinicalneurol.54.1214. Japanese.

PMID:
25672747
44.
45.

Acute thrombocytopenia after initiating anticoagulation with rivaroxaban.

Mima Y, Sangatsuda Y, Yasaka M, Wakugawa Y, Nagata S, Okada Y.

Intern Med. 2014;53(21):2523-7. Epub 2014 Nov 1.

46.

Two-week administration of rivaroxaban resolved left atrial thrombus.

Kato T, Yasaka M, Yabuki T, Adachi T, Toyoda S, Inoue T.

J Cardiol Cases. 2014 Sep 26;10(6):238-240. doi: 10.1016/j.jccase.2014.08.006. eCollection 2014 Dec.

47.
48.

[Appropriate administration of anticoagulants and antiplatelets].

Wakisaka K, Yasaka M.

Nihon Rinsho. 2014 Jul;72(7):1258-63. Review. Japanese.

PMID:
25163318
49.
50.

Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke - Research for Biomarkers in Ischemic Stroke (REBIOS).

Kuwashiro T, Ago T, Kamouchi M, Matsuo R, Hata J, Kuroda J, Fukuda K, Sugimori H, Fukuhara M, Awano H, Isomura T, Suzuki K, Yasaka M, Okada Y, Kiyohara Y, Kitazono T.

Metabolism. 2014 Sep;63(9):1093-103. doi: 10.1016/j.metabol.2014.04.012. Epub 2014 May 2.

PMID:
24929894

Supplemental Content

Loading ...
Support Center